Viewing Study NCT06956495


Ignite Creation Date: 2025-12-24 @ 1:47 PM
Ignite Modification Date: 2026-01-01 @ 11:00 PM
Study NCT ID: NCT06956495
Status: COMPLETED
Last Update Posted: 2025-10-22
First Post: 2025-04-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Tolerability of Tasipimidine in Sleepless Patients
Sponsor: Orion Corporation, Orion Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module